Search results
Found 12223 matches for
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
Sarah Howles
DPhil, FRCS (Urol), MA (Cantab), PGCert Sarah Howles - Principal Investigator, Wellcome Trust Clinical Career Development Fellow
Nicky Iyer
Nicky Iyer - Executive Assistant to the Head of Department and Senior Executive Officer
Annabell Roberti
BSc, MSc Annabell Roberti - Postdoctoral Researcher in Prostate Cancer Immune Regulation
Gurdeep S. Mannu
D.Phil FRCS Gurdeep S. Mannu - Cancer Research UK (CRUK) Clinician Scientist
Augustine Thambaiah Prabakumar
Augustine Thambaiah Prabakumar - GMP Production Scientist
Ashok Handa
MBBS, MA, FRCS (Eng), FRCS(Ed) Ashok Handa - Professor of Vascular Surgery and Director of Teaching in Surgery